Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.

about

Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy.

P2860

Q45874675-16CFD4EC-3527-4488-BC4C-97E5F7CA4B8F

P2860

Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.

Item

http://www.wikidata.org/entity/Q42367771

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Targeted genome editing restor ...... otent stem cell disease model.

@en

Targeted genome editing restor ...... otent stem cell disease model.

@nl

type

Item

label

Targeted genome editing restor ...... otent stem cell disease model.

@en

Targeted genome editing restor ...... otent stem cell disease model.

@nl

prefLabel

Targeted genome editing restor ...... otent stem cell disease model.

@en

Targeted genome editing restor ...... otent stem cell disease model.

@nl

P1476

Targeted genome editing restor ...... otent stem cell disease model.

@en

P2093

Celeste Pallant

http://www.w3.org/2001/XMLSchema#string

Claudio Mussolino

http://www.w3.org/2001/XMLSchema#string

Jamal Alzubi

http://www.w3.org/2001/XMLSchema#string

Steven J Howe

http://www.w3.org/2001/XMLSchema#string

P2860

Establishment in culture of pluripotential cells from mouse embryos

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Of mice and not men: differences between mouse and human immunology

Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution

Genome editing. The new frontier of genome engineering with CRISPR-Cas9

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

Genome editing with engineered zinc finger nucleases

Genetic engineering of human pluripotent cells using TALE nucleases

Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases

Concise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases.

P2888

s41598-017-12750-4

P304

12475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-12750-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Toni Cathomen

Adrian J Thrasher

P577

2017-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091963300

http://www.w3.org/2001/XMLSchema#string

P698

28963568

http://www.w3.org/2001/XMLSchema#string

P932

5622068

http://www.w3.org/2001/XMLSchema#string

Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.

about

P2860

P2860

Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P932